HHS plans stopgap to allow sales of some unapproved peptides: Washington Post
The Trump administration is preparing a stopgap that would allow certain previously restricted peptides to be sold temporarily while federal health officials write new regulations, according to an Oct. 7 Washington Post report citing two people familiar with the matter. The move would let some compounding pharmacies dispense peptides marketed as medical treatments and wellness […] The post HHS plans stopgap to allow sales of some unapproved peptides: Washington Post appeared first on Becke...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.